| Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer S Nirgude, B Choudhary Biochemical pharmacology 184, 114365, 2021 | 55 | 2021 |
| Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines J Koroth, S Nirgude, S Tiwari, V Gopalakrishnan, R Mahadeva, S Kumar, ... BMC complementary and alternative medicine 19, 1-16, 2019 | 53 | 2019 |
| ST09, a novel curcumin derivative, blocks cell migration by inhibiting matrix metalloproteases in breast cancer cells and inhibits tumor progression in EAC mouse tumor models S Nirgude, R Mahadeva, J Koroth, S Kumar, KSS Kumar, ... Molecules 25 (19), 4499, 2020 | 32 | 2020 |
| Quinacrine inhibits GSTA1 activity and induces apoptosis through G1/S arrest and generation of ROS in human non-small cell lung cancer cell lines M Kumar, A Martin, S Nirgude, B Chaudhary, S Mondal, A Sarkar Oncotarget 11 (18), 1603, 2020 | 15 | 2020 |
| Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis S Nirgude, S Desai, B Choudhary Cancer Reports 5 (10), e1596, 2022 | 12 | 2022 |
| ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in … S Nirgude, S Desai, R Mahadeva, F Ravindran, B Choudhary Frontiers in Oncology 12, 835027, 2022 | 11 | 2022 |
| Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development S Nirgude, NSS Naveh, SL Kavari, EM Traxler, JM Kalish British Journal of Cancer 130 (4), 638-650, 2024 | 1 | 2024 |
| Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09 S Nirgude, S Desai, B Choudhary BMC genomics 23 (1), 807, 2022 | 1 | 2022 |
| Transcriptomic profiling of Indian Breast Cancer patients revealed subtype-specific mRNA and lncRNA signatures JTBC Meghana Manjunath, Snehal Nirgude, Anisha Mhatre, Sai Gayatri Vemuri ... Frontiers in Genetics, 2022 | 1 | 2022 |
| A comprehensive study of mRNA and long noncoding RNAs in Indian Breast cancer patients using transcriptomics approach M Manjunath, S Nirgude, A Mhatre, SV Gayatri, M Nataraj, J Thumsi, ... bioRxiv, 2022.04. 13.488261, 2022 | 1 | 2022 |
| Single-nucleus multiomic analysis of Beckwith-Wiedemann syndrome liver reveals PPARA signaling enrichment and metabolic dysfunction S Nirgude, ED Tichy, Z Liu, RD Pradieu, M Byrne, LD Gil de Gomez, ... bioRxiv, 2024.06. 14.599077, 2024 | | 2024 |
| The counterpart congenital overgrowth syndromes Beckwith-Wiedemann Syndrome in human and large offspring syndrome in bovine involve alternations in DNA methylation … Y Li, P Xiao, F Boadu, AK Goldkamp, S Nirgude, J Cheng, DE Hagen, ... medRxiv, 2023.12. 14.23299981, 2023 | | 2023 |
| PP053 SP11, a promising coumarin-imidazothiadiazole derivative, targets HSP90 and client proteins to inhibit tumor growth MV Shahana, S Nirgude, F Ravindran, S Kumar, S Sharma, R Mahadeva, ... ESMO Open 8 (1), 2023 | | 2023 |
| Integration of exome-seq and mRNA-seq using DawnRank, identified genes involved in innate immunity as drivers of breast cancer in the Indian cohort S Nirgude, S Desai, V Khanchandani, V Nagarajan, J Thumsi, ... PeerJ 11, e16033, 2023 | | 2023 |
| Abstract A008: Cancer predisposition signaling pathways drive Beckwith-Wiedemann syndrome Wilms tumor oncogenesis SD Nirgude, NS Naveh, S Kavai, J Kalish Cancer Research 83 (16_Supplement), A008-A008, 2023 | | 2023 |
| A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins S Nirgude, MV Shahana, F Ravindran, S Kumar, S Sharma, R Mahadeva, ... Molecules 28 (13), 5226, 2023 | | 2023 |
| Curcumin derivative 1, 2-bis ((3E, 5E)-3, 5-bis (4-chlorobenzylidene)-4-oxopiperidine-1-yl) ethane-1, 2-dione hemihydrate, ST09, regulates miR-197-5p/GPX3 axis in breast cancer … S Nirgude, S Desai, F Ravindran, R Mahadeva, S Sharma, J Thumsi, ... | | 2022 |
| Methylation differences in cancer signaling pathways drive Beckwith-Wiedemann Syndrome Wilms Tumor oncogenesis NS Naveh, E Traxler, S Nirgude, J Kalish Cancer Research 82 (12_Supplement), 6045-6045, 2022 | | 2022 |
| Correction: Quinacrine inhibits GSTA1 activity and induces apoptosis through G1/S arrest and generation of ROS in human non-small cell lung cancer cell lines M Kumar, A Martin, S Nirgude, B Chaudhary, S Mondal, A Sarkar Oncotarget 11 (46), 4364, 2020 | | 2020 |
| Novel biomarkers by transcriptomic and miRNA profiling of patients with breast cancer in India J Thumsi, S Nirgude, S Jadhav, M Manjunath, B Choudhary, M Natraj, ... European Journal of Cancer 92, S132-S133, 2018 | | 2018 |
Bibha ChoudharyProfessor在 ibab.ac.in 的电子邮件经过验证
